|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.74 USD | -4.14% |
|
-8.77% | -9.78% |
| 07-30 | Viking's Obesity Treatments Advance as New Data, Trials Loom, Oppenheimer Says | MT |
| 07-30 | Viking Therapeutics' Q2 Net Loss Widens | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 36.37 | 42.13 | 39.11 |
| Spread/Res. | -12.73% | -24.66% | -18.84% |
| Spread/Supp. | +4.10% | +20.73% | +27.93% |
| Support | 30.49 | 26.29 | 24.81 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VKTX Stock
- Charts Viking Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
